Acute cerebellar dysfunction with neuromuscular manifestations after scorpionism presumably caused by Tityus obscurus in Santarem, Para/Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2015
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
TOXICON, v.96, n.1, p.68-73, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Scorpionism is a public health problem in many tropical countries, especially in North Africa, South India, Latin America and the Middle East. In Brazil, patients with severe scorpion envenoming have mainly cardiovascular events, including acute heart failure, acute respiratory distress syndrome and shock, death is rare. We described 58 accidents presumably caused by Tityus obscurus in Brazilian Amazonia. Patients reported a sensation of ""electric shocks"" which could last hours. The vast majority of patients presented a clinical picture compatible with acute cerebellar dysfunction, beginning minutes and lasting up to 2 days after the accident. They presented cerebellar ataxia, dysdiadochokinesia, dysmetry, dysarthria, dyslalia, nausea and vomiting. Besides, some patients presented myoclonus and fasciculation which can also be attributed to cerebellar dysfunction or maybe the result of direct action on skeletal muscle. Two patients had evidence of intense rhabdomyolysis and acute kidney injury. The clinical picture in this scorpion envenoming is mainly characterized by an acute dysfunction of cerebellar activities and abnormal neuromuscular manifestations and in some cases muscle injury which are not described in any other region of the world. This work presents clinical, epidemiologic, laboratory and treatment aspects of this unmatched scorpion envenoming in the state of Para, northern Brazil.
Palavras-chave
Scorpion sting, Envenomation, Cerebellum, Tityus, Amazonia
Referências
  1. Amaral C.F., 1991, AM J CARDIOL, V67, P665
  2. AMARAL CFS, 1994, TOXICON, V32, P211, DOI 10.1016/0041-0101(94)90110-4
  3. AMARAL CFS, 1993, AM J CARDIOL, V71, P242, DOI 10.1016/0002-9149(93)90746-Y
  4. Angsanakul J, 2013, TOXICON, V73, P81, DOI 10.1016/j.toxicon.2013.06.023
  5. Batista CVF, 2007, COMP BIOCHEM PHYS C, V146, P147, DOI 10.1016/j.cbpc.2006.12.004
  6. Batista CVF, 2002, TOXICON, V40, P557, DOI 10.1016/S0041-0101(01)00252-5
  7. Batista CVF, 2002, BBA-PROTEINS PROTEOM, V1601, P123, DOI 10.1016/S1570-9639(02)00458-2
  8. Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002
  9. Batista CVF, 2000, FEBS LETT, V486, P117, DOI 10.1016/S0014-5793(00)02253-5
  10. Borja-Oliveira CR, 2009, COMP BIOCHEM PHYS C, V149, P404, DOI 10.1016/j.cbpc.2008.09.014
  11. Brazil T.K., 2010, OS ESCORPIOES, V1, P90
  12. Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103
  13. Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022
  14. Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021
  15. Cupo P., 2009, ANIMAIS PECONHENTOS
  16. Cupo Palmira, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P67
  17. Cupo P, 2007, INT J CARDIOL, V116, P98, DOI 10.1016/j.ijcard.2006.02.015
  18. de Roodt AR, 2003, TOXICON, V41, P971, DOI 10.1016/S0041-0101(03)00066-7
  19. Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121
  20. Gordon D, 1998, J TOXICOL-TOXIN REV, V17, P131
  21. Guerrero-Vargas J.A., 2012, PLOS ONE, V7, P1
  22. Khattabi A, 2011, T ROY SOC TROP MED H, V105, P364, DOI 10.1016/j.trstmh.2011.03.007
  23. Lewin GR, 2013, SCIENCE, V342, P428, DOI 10.1126/science.1244375
  24. Lourenco W.R., 2008, OCCASIONAL PUBLICATI, V75, p[1, 1]
  25. *MIN SAUD, 1998, MAN DIAGN TRAT AC AN
  26. Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441
  27. Murgia AR, 2004, TOXICON, V43, P737, DOI 10.1016/j.toxicon.2004.02.014
  28. Pardal P.P., 2013, J VENOM ANIM TOXINS, V20, P3
  29. Pardal Pedro Pereira de Oliveira, 2003, Rev Soc Bras Med Trop, V36, P349, DOI 10.1590/S0037-86822003000300006
  30. Petricevich V.L., 2010, MEDIAT INFLAMM
  31. Possani LD, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P339, DOI 10.1016/B978-012369442-3/50054-4
  32. Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x
  33. Prestipino G, 2009, TOXICOL LETT, V187, P1, DOI 10.1016/j.toxlet.2009.01.027
  34. Romeo S, 2008, BBA-GEN SUBJECTS, V1780, P750, DOI 10.1016/j.bbagen.2008.01.012
  35. Satu M., 2005, BASIC APPL MYOL, V15, P23
  36. Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424
  37. Sitprija V, 2012, TOXICON, V60, P943, DOI 10.1016/j.toxicon.2012.06.012
  38. Stalin Viswanathan, 2011, NDT Plus, V4, P376, DOI 10.1093/ndtplus/sfr148
  39. Weiss MF, 2010, CLIN NEPHROL, V73, P64, DOI 10.2379/CN106171